Skip to main content
. 2017 Mar 18;8(19):31532–31539. doi: 10.18632/oncotarget.16360

Table 1. Comparison of clinicopathological data among groups of IPNG and IPNB.

IPNG IPNB P value
IPNG-1 IPNG-2 P value IPNB-1 IPNB-2 P value
Demographic
 Age (year) 56.5 ± 16.9 65.8 ± 17.2 0.135 59.7 ± 1 1.5 56.1 ± 12.7 0.445 0.261
 Gender (M:F) 8:7 6:11 0.476 6:4 11:11 0.712 0.453
Symptoms
 Abdominal pain 8/15§ 8/17 1.000 5/10§ 7/22 0.438 0.313
 Jaundice 1/15 2/17 1.000 4/10 16/22 0.119 < 0.001
 Fever 2/15 3/17 1.000 4/10 5/22 0.407 0.226
 Weight loss 3/15 6/17 0.444 5/10 12/22 1.000 0.042
Biliary stones 7/15 6/17 0.720 3/10 1/22 0.079 0.011
Liver function tests
 ALT 1/15 2/16 1.000 5/10 17/22 0.217 < 0.001
 TBil 1/15 3/16 0.600 6/10 14/22 1.000 < 0.001
 DBil 1/15 2/16 1.000 5/10 15/22 0.438 < 0.001
 GGT 4/15 3/16 0.685 6/10 20/22 0.060 < 0.001
 ALP 1/15 2/16 1.000 6/10 15/22 0.703 < 0.001
Tumor markers
 CEA 0/7 4/13 0.249 1/10 4/22 1.000 0.977
 CA19-9 2/7 2/14 0.574 5/10 15/21 0.423 0.001
Pathological features
 Multiple lesions (≥ 2) 4/15 5/17 1.000 2/10 4/22 1.000 0.376
 Size (cm) 1.5 ± 1.2 4.0 ± 2.2 < 0.001 2.3 ± 1.3 2.3 ± 1.1 0.944 0.231
 Lymphatic metastasis 1/14 4/17 0.344 0/10 4/21 0.227 1.000
 Positive margin 0/15 3/17 0.229 0/10 5/22 0.155 0.705
Histological subtype 1.000 0.019 0.923
 Pancreaticobiliary 5/12 7/15 7/9 4/16
 Intestinal 6/12 7/15 1/9 10/16
 Oncocytic 1/12 1/15 1/9 2/16
 Gastric 0/12 0/15 0/9 0/16

Note. §Number of positive cases /total number of cases with available data.

Abbreviations: ALT, alanine aminotransferase; TBil, total bilirubin; DBil, direct bilirubin; GGT, γ-glutamyl transpeptidase; ALP, alkaline phosphatase; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9.